{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:44:36Z","timestamp":1761561876915},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"1066","license":[{"start":{"date-parts":[[2014,6,3]],"date-time":"2014-06-03T00:00:00Z","timestamp":1401753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Critically ill patients are considered to be most at risk from developing non-variceal upper gastrointestinal bleeding (NVGIB) while in hospital. The increasing prescription of low-dose aspirin and other antithrombotic drugs for protection against thromboembolism to many patients admitted to hospital may increase the vulnerability of a wider group to NVGIB.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This study compares two groups of patients with NVGIB: group I, inpatients cared for outside the intensive care unit; and group II, patients admitted with this condition, while considering the use of antithrombotic drugs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We identified all patients who developed NVGIB in the two calendar years between 2008 and 2009 and compared group I with group II while taking into account their clinical details including Rockall scores and drug usage.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Compared with group II (n=274), group I (n=96) were older (median age of 77\u2005years vs 68; p&amp;lt;0.001), had fewer males (45.8% vs 60.6%; p=0.016), higher prevalence of cardiovascular disease (52.1% vs 29.2%; p&amp;lt;0.001), more patients with complete Rockall score \u22653 (84.4% vs 66.7%; p=0.001) and more patients treated with aspirin or other antithrombotic drugs (64.6% vs 44.5%; p=0.001). After adjustment for age and sex, group I were still significantly more likely to be taking antithrombotic drugs than group II (OR (95% CIs), 2.15 (1.25 to 3.68); p=0.006). The endoscopic abnormalities in more than 80% of patients included erosive oesophagitis, gastric or duodenal ulcers or erosions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Subjects who develop NVGIB as inpatients have higher Rockall scores are mainly older females with cardiovascular disease and using antithrombotic drugs. Secondary care clinicians should be mindful of this at-risk group of patients and consider giving them prophylactic antiulcer therapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/postgradmedj-2013-132231","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T06:33:38Z","timestamp":1401863618000},"page":"429-433","update-policy":"http:\/\/dx.doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Upper gastrointestinal bleeding in hospital inpatients: the role of antithrombotic drugs"],"prefix":"10.1093","volume":"90","author":[{"given":"Ali S","family":"Taha","sequence":"first","affiliation":[{"name":"Gastroenterology Unit, University Hospital Crosshouse , Kilmarnock , UK"},{"name":"School of Medicine, University of Glasgow , Glasgow , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Kelly","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit, University Hospital Crosshouse , Kilmarnock , UK"},{"name":"School of Medicine, University of Glasgow , Glasgow , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"McCloskey","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit, University Hospital Crosshouse , Kilmarnock , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Craigen","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit, University Hospital Crosshouse , Kilmarnock , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilson J","family":"Angerson","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Glasgow , Glasgow , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,6,3]]},"reference":[{"key":"2023041905561960900_R1","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1365-2036.2007.03458.x","article-title":"Upper gastrointestinal bleeding and the changing use of COX-2 non-steroidal anti-inflammatory drugs and low-dose aspirin","volume":"26","author":"Taha","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"2023041905561960900_R2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2036.2010.04563.x","article-title":"The changing face of hospitalization due to gastrointestinal bleeding and perforation","volume":"33","author":"Lanas","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"2023041905561960900_R3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cgh.2010.01.002","article-title":"Reduced hospitalization cost for upper gastrointestinal events that occur among elderly veterans who are gastroprotected","volume":"8","author":"Abraham","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2023041905561960900_R4","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0140-6736(96)90607-8","article-title":"Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage","volume":"347","author":"Rockall","year":"1996","journal-title":"Lancet"},{"key":"2023041905561960900_R5","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0140-6736(00)02816-6","article-title":"A risk score to predict need for treatment for upper gastrointestinal haemorrhage","volume":"356","author":"Blatchford","year":"2000","journal-title":"Lancet"},{"key":"2023041905561960900_R6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ajg.2008.62","article-title":"the RUGBE investigators. Non-variceal upper GI bleeding in patients already hospitalized for another condition","volume":"104","author":"Muller","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"2023041905561960900_R7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1056\/NEJM199402103300601","article-title":"Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group","volume":"330","author":"Cook","year":"1994","journal-title":"N Engl J Med"},{"key":"2023041905561960900_R8","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1111\/j.1572-0241.2000.03189.x","article-title":"Clinically significant gastrointestinal bleeding in critically ill patients in an era of prophylaxis","volume":"95","author":"Pimentel","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"2023041905561960900_R9","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/fg.2011.004572","article-title":"Mortality following blood transfusion for non-variceal upper gastrointestinal bleeding","volume":"2","author":"Taha","year":"2011","journal-title":"Frontline Gastroenterology"},{"key":"2023041905561960900_R10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/flgastro-2012-100280","article-title":"Gastroprotective policy and the incidence of upper gastrointestinal bleeding","volume":"4","author":"Taha","year":"2013","journal-title":"Frontline Gastroenterology"},{"key":"2023041905561960900_R11","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S","article-title":"A simple method of sample size calculation for linear and logistic regression","volume":"17","author":"Hsieh","year":"1998","journal-title":"Statist Med"},{"key":"2023041905561960900_R12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jhm.10","article-title":"Hospital acquired gastrointestinal bleeding outside the critical care unit","volume":"1","author":"Qadeer","year":"2006","journal-title":"J Hosp Med"},{"key":"2023041905561960900_R13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(09)61246-0","article-title":"Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase-III, randomised, double-blind, placebo-controlled trial","volume":"374","author":"Taha","year":"2009","journal-title":"Lancet"},{"key":"2023041905561960900_R14","author":"FDA","year":"2012"},{"key":"2023041905561960900_R15","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ajg.2012.108","article-title":"Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis","volume":"107","author":"Kwok","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"2023041905561960900_R16","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.cgh.2006.04.010","article-title":"Consensus development conference on the use of non-steroidal antiinflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin","volume":"4","author":"Wilcox","year":"2006","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/90\/1066\/429\/50003972\/postgradmedj-90-429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/90\/1066\/429\/50003972\/postgradmedj-90-429.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T06:02:41Z","timestamp":1681884161000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/90\/1066\/429\/6992031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,3]]},"references-count":16,"journal-issue":{"issue":"1066","published-online":{"date-parts":[[2014,6,3]]},"published-print":{"date-parts":[[2014,8,1]]}},"URL":"https:\/\/doi.org\/10.1136\/postgradmedj-2013-132231","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,8]]},"published":{"date-parts":[[2014,6,3]]}}}